IBDEI0T9 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13165,1,4,0)
 ;;=4^H16.101
 ;;^UTILITY(U,$J,358.3,13165,2)
 ;;=^5004898
 ;;^UTILITY(U,$J,358.3,13166,0)
 ;;=H16.103^^51^629^77
 ;;^UTILITY(U,$J,358.3,13166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13166,1,3,0)
 ;;=3^Superficial Keratitis,Unspec,OU
 ;;^UTILITY(U,$J,358.3,13166,1,4,0)
 ;;=4^H16.103
 ;;^UTILITY(U,$J,358.3,13166,2)
 ;;=^5004900
 ;;^UTILITY(U,$J,358.3,13167,0)
 ;;=H17.9^^51^629^24
 ;;^UTILITY(U,$J,358.3,13167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13167,1,3,0)
 ;;=3^Corneal Scar & Opacity,Unspec
 ;;^UTILITY(U,$J,358.3,13167,1,4,0)
 ;;=4^H17.9
 ;;^UTILITY(U,$J,358.3,13167,2)
 ;;=^5005003
 ;;^UTILITY(U,$J,358.3,13168,0)
 ;;=H21.9^^51^629^44
 ;;^UTILITY(U,$J,358.3,13168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13168,1,3,0)
 ;;=3^Iris & Ciliary Body Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13168,1,4,0)
 ;;=4^H21.9
 ;;^UTILITY(U,$J,358.3,13168,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,13169,0)
 ;;=H18.501^^51^629^38
 ;;^UTILITY(U,$J,358.3,13169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13169,1,3,0)
 ;;=3^Hereditary Corneal Dystrophies,Unspec,Rt Eye
 ;;^UTILITY(U,$J,358.3,13169,1,4,0)
 ;;=4^H18.501
 ;;^UTILITY(U,$J,358.3,13169,2)
 ;;=^5159175
 ;;^UTILITY(U,$J,358.3,13170,0)
 ;;=H18.502^^51^629^37
 ;;^UTILITY(U,$J,358.3,13170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13170,1,3,0)
 ;;=3^Hereditary Corneal Dystrophies,Unspec,Lt Eye
 ;;^UTILITY(U,$J,358.3,13170,1,4,0)
 ;;=4^H18.502
 ;;^UTILITY(U,$J,358.3,13170,2)
 ;;=^5159176
 ;;^UTILITY(U,$J,358.3,13171,0)
 ;;=H18.503^^51^629^36
 ;;^UTILITY(U,$J,358.3,13171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13171,1,3,0)
 ;;=3^Hereditary Corneal Dystrophies,Unspec,Bilateral
 ;;^UTILITY(U,$J,358.3,13171,1,4,0)
 ;;=4^H18.503
 ;;^UTILITY(U,$J,358.3,13171,2)
 ;;=^5159177
 ;;^UTILITY(U,$J,358.3,13172,0)
 ;;=H18.511^^51^629^29
 ;;^UTILITY(U,$J,358.3,13172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13172,1,3,0)
 ;;=3^Endothelial Corneal Dystrophy,Rt Eye
 ;;^UTILITY(U,$J,358.3,13172,1,4,0)
 ;;=4^H18.511
 ;;^UTILITY(U,$J,358.3,13172,2)
 ;;=^5159179
 ;;^UTILITY(U,$J,358.3,13173,0)
 ;;=H18.512^^51^629^28
 ;;^UTILITY(U,$J,358.3,13173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13173,1,3,0)
 ;;=3^Endothelial Corneal Dystrophy,Lt Eye
 ;;^UTILITY(U,$J,358.3,13173,1,4,0)
 ;;=4^H18.512
 ;;^UTILITY(U,$J,358.3,13173,2)
 ;;=^5159180
 ;;^UTILITY(U,$J,358.3,13174,0)
 ;;=H18.513^^51^629^27
 ;;^UTILITY(U,$J,358.3,13174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13174,1,3,0)
 ;;=3^Endothelial Corneal Dystrophy,Bilateral
 ;;^UTILITY(U,$J,358.3,13174,1,4,0)
 ;;=4^H18.513
 ;;^UTILITY(U,$J,358.3,13174,2)
 ;;=^5159181
 ;;^UTILITY(U,$J,358.3,13175,0)
 ;;=H40.10X4^^51^630^5
 ;;^UTILITY(U,$J,358.3,13175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13175,1,3,0)
 ;;=3^OAG,Unspec,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,13175,1,4,0)
 ;;=4^H40.10X4
 ;;^UTILITY(U,$J,358.3,13175,2)
 ;;=^5005752
 ;;^UTILITY(U,$J,358.3,13176,0)
 ;;=H40.10X1^^51^630^2
 ;;^UTILITY(U,$J,358.3,13176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13176,1,3,0)
 ;;=3^OAG,Unspec,Mild Stage
 ;;^UTILITY(U,$J,358.3,13176,1,4,0)
 ;;=4^H40.10X1
 ;;^UTILITY(U,$J,358.3,13176,2)
 ;;=^5005749
 ;;^UTILITY(U,$J,358.3,13177,0)
 ;;=H40.10X2^^51^630^3
 ;;^UTILITY(U,$J,358.3,13177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13177,1,3,0)
 ;;=3^OAG,Unspec,Moderate Stage
 ;;^UTILITY(U,$J,358.3,13177,1,4,0)
 ;;=4^H40.10X2
